Aphios Awarded National Institutes of Health (NIH) ARRA Challenge Grant for Pathogen Inactivation Technology for Blood Products

Published: Sep 30, 2009

WOBURN, Mass.--(BUSINESS WIRE)--Aphios Corporation today announced that it has been awarded a RC-1 Challenge grant (No. 1RC1HL102822-01) from the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health’s (NIH) American Recovery and Reinvestment Act (ARRA) funds to develop a generally-applicable pathogen inactivation technology for blood products.

Back to news